Taste-masked oral pharmaceutical composition
The invention provides coated particles with a taste-masked drug substance. The particles comprise a core with the agglomerated active ingredient and a coating comprising a triglyceride and a surfactant. The particles exhibit rapid drug release and a stable release profile. Moreover, the invention provides a hot-melt coating method for manufacturing such particles, and pharmaceutical compositions comprising the particles. The method allows the coating of core particles at moderate temperatures, thereby preventing the degradation of the thermolabile active ingredient.
1. An immediate release particle comprising a core and a coating, wherein the core consists of an agglomerated granule or pellet having a diameter in the range from about 100 μm to about 1000 μm, which core consists of an agglomerated active ingredient, and wherein the coating consists of a triglyceride which is solid at room temperature and a polysorbate surfactant.
2. The particle of claim 1 , wherein the triglyceride comprises at least one acyl chain having 16 to 18 carbon atoms.
3. The particle of claim 1 , wherein the surfactant is polysorbate 65 or polysorbate 85.
4. The particle of claim 3 , wherein the polysorbate is polysorbate 65.
5. The particle of claim 1 , wherein the coating comprises from 70 to 90 wt.-% triglyceride and from 10 to 30 wt.-% polysorbate.
6. The particle of claim 1 , wherein the particle consists of the core and the coating.
7. The particle of claim 1 , wherein the weight of the coating is from 20 to 70 wt.-% relative to the total weight of the coated particle.
8. The particle of claim 1 , wherein the core has a diameter in the range from about 200 μm to about 500 μm.
9. The particle of claim 1 , wherein the active ingredient is agglomerated ibuprofen or ibuprofen sodium salt.
10. The particle of claim 1 , wherein the active ingredient comprises crystals of active ingredient.
11. The particle of claim 1 , wherein the granule or pellet is prepared by wet or dry granulation.
12. The particle of claim 2 , wherein the triglyceride is selected from tripalmitin and tristearin.
13. A pharmaceutical composition comprising the particle of claim 1 .
14. The pharmaceutical composition of claim 13 , wherein the composition is formulated as granules or as a tablet.
15. The pharmaceutical composition of claim 14 , wherein the granules are dispersible granules, effervescent granules, or direct-to-mouth granules.
16. The pharmaceutical composition of claim 14 , wherein the tablet is a dispersible tablet, an effervescent tablet, or an orally disintegrating tablet.
17. A method for the preparation of the particle of claim 1 , comprising the steps of
(a) providing a core particle consisting of an agglomerated active ingredient,
(b) providing a coating composition consisting of a molten triglyceride which is a solid at room temperature and a polysorbate surfactant, and
(c) coating the core particle with the coating composition.
18. The method of claim 17 , wherein the product temperature is kept between about 20 and 50° C. while performing step (c), and/or wherein step (c) is performed in a fluid-bed coater or air flow bed coater.
19. A particle comprising a core and a coating, wherein the core consists of an agglomerated granule or pellet having a diameter in the range from about 100 μm to about 1000 μm, which consists of an agglomerated active ingredient, and wherein the coating consists of a triglyceride which is solid at room temperature and a polysorbate surfactant, said particle being obtainable by a method comprising the steps of
(a) providing a core particle consisting of an agglomerated active ingredient,
(b) providing a coating composition consisting of a molten triglyceride which is a solid at room temperature and a polysorbate surfactant, and
(c) coating the core particle with the coating composition.